1887
Research Open Access
Like 0

Abstract

Introduction

The detection of SARS-CoV-2 with rapid diagnostic tests (RDT) has become an important tool to identify infected people and break infection chains. These RDT are usually based on antigen detection in a lateral flow approach.

Aim

We aimed to establish a comprehensive specimen panel for the decentralised technical evaluation of SARS-CoV-2 antigen rapid diagnostic tests.

Methods

While for PCR diagnostics the validation of a PCR assay is well established, there is no common validation strategy for antigen tests, including RDT. In this proof-of-principle study we present the establishment of a panel of 50 pooled clinical specimens that cover a SARS-CoV-2 concentration range from 1.1 × 109 to 420 genome copies per mL of specimen. The panel was used to evaluate 31 RDT in up to six laboratories.

Results

Our results show that there is considerable variation in the detection limits and the clinical sensitivity of different RDT. We show that the best RDT can be applied to reliably identify infectious individuals who present with SARS-CoV-2 loads down to 106 genome copies per mL of specimen. For the identification of infected individuals with SARS-CoV-2 loads corresponding to less than 106 genome copies per mL, only three RDT showed a clinical sensitivity of more than 60%.

Conclusions

Sensitive RDT can be applied to identify infectious individuals with high viral loads but not to identify all infected individuals.

Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2021.26.44.2100442
2021-11-04
2021-11-29
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2021.26.44.2100442
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/26/44/eurosurv-26-44-2.html?itemId=/content/10.2807/1560-7917.ES.2021.26.44.2100442&mimeType=html&fmt=ahah

References

  1. Nalla AK, Casto AM, Huang MW, Perchetti GA, Sampoleo R, Shrestha L, et al. Comparative performance of SARS-CoV-2 detection assays using seven different primer-probe sets and one assay kit. J Clin Microbiol. 2020;58(6):e00557-20.  https://doi.org/10.1128/JCM.00557-20  PMID: 32269100 
  2. Mackay IM, Arden KE, Nitsche A. Real-time fluorescent PCR techniques to study microbial-host interactions. In: Savidge T, Pothulakis C, editors. Microbial Imaging. Methods in Microbiology vol. 34, Amsterdam: Elsevier/Academic Press; 2004, p.: 255-330.  https://doi.org/10.1016/S0580-9517(04)34010-9 
  3. Peeling RW, McNerney R. Emerging technologies in point-of-care molecular diagnostics for resource-limited settings. Expert Rev Mol Diagn. 2014;14(5):525-34.  https://doi.org/10.1586/14737159.2014.915748  PMID: 24784765 
  4. Strömer A, Rose R, Schäfer M, Schön F, Vollersen A, Lorentz T, et al. Performance of a point-of-care test for the rapid detection of SARS-CoV-2 antigen. Microorganisms. 2020;9(1):58.  https://doi.org/10.3390/microorganisms9010058  PMID: 33379279 
  5. Jacobs J, Kühne V, Lunguya O, Affolabi D, Hardy L, Vandenberg O. Implementing COVID-19 (SARS-CoV-2) rapid diagnostic tests in Sub-Saharan Africa: a review. Front Med (Lausanne). 2020;7:557797.  https://doi.org/10.3389/fmed.2020.557797  PMID: 33195307 
  6. Kozel TR, Burnham-Marusich AR. Point-of-care testing for infectious diseases: past, present, and future. J Clin Microbiol. 2017;55(8):2313-20.  https://doi.org/10.1128/JCM.00476-17  PMID: 28539345 
  7. Berzosa P, de Lucio A, Romay-Barja M, Herrador Z, González V, García L, et al. Comparison of three diagnostic methods (microscopy, RDT, and PCR) for the detection of malaria parasites in representative samples from Equatorial Guinea. Malar J. 2018;17(1):333.  https://doi.org/10.1186/s12936-018-2481-4  PMID: 30223852 
  8. FIND evaluation of SARS-CoV-2 antigen (Ag) detecting tests. Geneva: FIND. [Accessed: 20 Oct 2021]. Available from: https://www.finddx.org/sarscov2-eval-antigen
  9. Michel J, Neumann M, Krause E, Rinner T, Muzeniek T, Grossegesse M, et al. Resource-efficient internally controlled in-house real-time PCR detection of SARS-CoV-2. Virol J. 2021;18(1):110.  https://doi.org/10.1186/s12985-021-01559-3  PMID: 34078394 
  10. Scheiblauer H, Filomena A, Nitsche A, Puyskens A, Corman VM, Drosten C, et al. Comparative sensitivity evaluation for 122 CE-marked SARS-CoV-2 antigen rapid tests. Euro Surveill. 2021;26(44):2100441.
  11. Wölfel R, Corman VM, Guggemos W, Seilmaier M, Zange S, Müller MA, et al. Virological assessment of hospitalized patients with COVID-2019. Nature. 2020;581(7809):465-9.  https://doi.org/10.1038/s41586-020-2196-x  PMID: 32235945 
  12. Kim M-C, Cui C, Shin K-R, Bae J-Y, Kweon O-J, Lee M-K, et al. Duration of culturable SARS-CoV-2 in hospitalized patients with Covid-19. N Engl J Med. 2021;384(7):671-3.  https://doi.org/10.1056/NEJMc2027040  PMID: 33503337 
  13. van Kampen JJA, van de Vijver DAMC, Fraaij PLA, Haagmans BL, Lamers MM, Okba N, et al. Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19). Nat Commun. 2021;12(1):267.  https://doi.org/10.1038/s41467-020-20568-4  PMID: 33431879 
  14. La Scola B, Le Bideau M, Andreani J, Hoang VT, Grimaldier C, Colson P, et al. Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards. Eur J Clin Microbiol Infect Dis. 2020;39(6):1059-61.  https://doi.org/10.1007/s10096-020-03913-9  PMID: 32342252 
  15. World Health Organization (WHO). COVID-19 target product profiles for priority diagnostics to support response to the COVID-19 pandemic v.1.0. Geneva: WHO; 2020. Available from: https://www.who.int/publications/m/item/covid-19-target-product-profiles-for-priority-diagnostics-to-support-response-to-the-covid-19-pandemic-v.0.1
  16. Berger A, Nsoga MTN, Perez-Rodriguez FJ, Aad YA, Sattonnet-Roche P, Gayet-Ageron A, et al. Diagnostic accuracy of two commercial SARS-CoV-2 antigen-detecting rapid tests at the point of care in community-based testing centers. PLoS One. 2021;16(3):e0248921.  https://doi.org/10.1371/journal.pone.0248921  PMID: 33788882 
  17. Mboumba Bouassa RS, Veyer D, Péré H, Bélec L. Analytical performances of the point-of-care SIENNA™ COVID-19 Antigen Rapid Test for the detection of SARS-CoV-2 nucleocapsid protein in nasopharyngeal swabs: A prospective evaluation during the COVID-19 second wave in France. Int J Infect Dis. 2021;106:8-12.  https://doi.org/10.1016/j.ijid.2021.03.051  PMID: 33746093 
  18. Olearo F, Nörz D, Heinrich F, Sutter JP, Roedl K, Schultze A, et al. Handling and accuracy of four rapid antigen tests for the diagnosis of SARS-CoV-2 compared to RT-qPCR. J Clin Virol. 2021;137:104782.  https://doi.org/10.1016/j.jcv.2021.104782  PMID: 33711691 
  19. Corman VM, Haage VC, Bleicker T, Schmidt ML, Mühlemann B, Zuchowski M, et al. Comparison of seven commercial SARS-CoV-2 rapid point-of-care antigen tests: a single-centre laboratory evaluation study. Lancet Microbe. 2021;2(7):e311-9.  https://doi.org/10.1016/S2666-5247(21)00056-2  PMID: 33846704 
  20. Pollock NR, Savage TJ, Wardell H, Lee R, Mathew A, Stengelin M, et al. Correlation of SARS-CoV-2 nucleocapsid antigen and RNA concentrations in nasopharyngeal samples from children and adults using an ultrasensitive and quantitative antigen assay. Preprint. MedRxiv. 2020:11.10.20227371.  https://doi.org/10.1101/2020.11.10.20227371 
  21. Kohmer N, Toptan T, Pallas C, Karaca O, Pfeiffer A, Westhaus S, et al. The comparative clinical performance of four SARS-CoV-2 rapid antigen tests and their correlation to infectivity in vitro. J Clin Med. 2021;10(2):328.  https://doi.org/10.3390/jcm10020328  PMID: 33477365 
  22. Basile K, McPhie K, Carter I, Alderson S, Rahman H, Donovan L, et al. Cell-based culture of SARS-CoV-2 informs infectivity and safe de-isolation assessments in patients during COVID-19. Clin Infect Dis. 2020;ciaa1579.  https://doi.org/10.1093/cid/ciaa1579  PMID: 33098412 
  23. Boyce MR, Menya D, Turner EL, Laktabai J, Prudhomme-O’Meara W. Evaluation of malaria rapid diagnostic test (RDT) use by community health workers: a longitudinal study in western Kenya. Malar J. 2018;17(1):206.  https://doi.org/10.1186/s12936-018-2358-6  PMID: 29776359 
  24. Baro B, Rodo P, Ouchi D, Bordoy AE, Saya Amaro EN, Salsench SV, et al. Performance characteristics of five antigen-detecting rapid diagnostic test (Ag-RDT) for SARS-CoV-2 asymptomatic infection: a head-to-head benchmark comparison. J Infect. 2021;82(6):269-75.  https://doi.org/10.1016/j.jinf.2021.04.009  PMID: 33882299 
  25. Dinnes J, Deeks JJ, Adriano A, Berhane S, Davenport C, Dittrich S, et al. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection. Cochrane Database Syst Rev. 2020;8:CD013705.  https://doi.org/10.1002/14651858.CD013705  PMID: 32845525 
/content/10.2807/1560-7917.ES.2021.26.44.2100442
Loading

Data & Media loading...

Supplementary data

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error